Image (33ea875e Cb1b 4508 B538 07828d828e10 01)
Sitagliptin And Metformin Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 70710-2037
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 70710-2037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (33ea875e Cb1b 4508 B538 07828d828e10 02)
Image (33ea875e Cb1b 4508 B538 07828d828e10 03)
Image (33ea875e Cb1b 4508 B538 07828d828e10 04)
Not available.*
50 mg/ 500 mg (33ea875e Cb1b 4508 B538 07828d828e10 05)
Sitagliptin and Metformin Hydrochloride is an oral medication available in 50mg/500mg extended-release tablets. The recommended dosage is two tablets taken once daily with a meal, preferably in the evening. It is important to use the medication within 30 days of opening. The package is child-resistant and should be stored at 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). Keep the tablets in a dry place with the cap tightly closed and in the original container to protect them from moisture. Contact the provided number for further information or discard the medication after use. Manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*
50 mg/1000 mg (33ea875e Cb1b 4508 B538 07828d828e10 06)
This is a description of Sitagliptin and Metformin Hydrochloride Extended-Release Tablets, for oral use. Each film-coated tablet contains Sitagliptin 50 mg and Metformin Hydrochloride, USP 1,000 mg. The recommended dosage is two tablets taken once daily with a meal, preferably in the evening. The package is child-resistant and should be stored at 20°C to 25°C (66°F to 77°F), with excursions permitted from 15°C to 30°C (59°F to 86°F). It should be stored in a dry place with the cap tightly closed and dispensed in the original container. It is advised to keep the tablets in the original container to protect them from moisture. The medication guide is available at zydususa.com/medguides or by calling 1-877-993-8775. This medication is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*
100 mg/1000 mg (33ea875e Cb1b 4508 B538 07828d828e10 07)
This text provides information about Sitagliptin and Metformin Hydrochloride Extended-Release Tablets, which contain 100mg of Sitagliptin and 1,000mg of Metformin Hydrochloride each. The tablets are recommended to be taken once daily with a meal, preferably in the evening. The package is child-resistant and should be stored at 20°C to 25°C. The tablets should be used within 30 days of opening and kept in the original container to protect them from moisture. For further guidance or inquiries, contact Zydus Lifesciences Ltd. in Ahmedabad, India, or Zydus Pharmaceuticals (USA) Inc. in Pennington, New Jersey.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
